Covid-19 Live Updates: C.D.C. Panel to Weigh In on J.&J. Vaccine Pause

The panel is discussing a handful of new, confirmed cases of a rare blood clotting disorder in Johnson & Johnson vaccine recipients reported by the agency, which said the overall risk of developing the illness appeared to be extremely low. The U.S. government is likely to end the pause of the vaccine if the panel says the shot’s benefits during the pandemic outweigh the potential risk. In India, which recorded more than 330,000 cases in 24 hours, the second consecutive global record, hospitals plead for oxygen.